title: Adherence to antiretroviral therapy in Nigeria: an overview of research studies and implications for policy and practice.
abstract: Both Human Immunodeficiency Virus (HIV) infection and AIDS remain major public health crises in Nigeria, a country which harbors more people living with HIV/AIDS than any country in the world, with the exception of South Africa and India. In response to the HIV pandemic, global and international health initiatives have targeted several countries, including Nigeria, for the expansion of antiretroviral therapy (ART) programs for the increasing number of affected patients. The success of these expanded ART initiatives depends on the treated individual's continual adherence to antiretroviral (ARV) drugs. Thirteen peer-reviewed studies concerning adherence to ART in Nigeria were reviewed with very few pediatric and adolescent studies being found. Methodologies of adherence measurement were analyzed and reasons for nonadherence were identified in the geopolitical zones in the federal republic of Nigeria. The results of the literature review indicate that adherence to ART is mixed (both high and low adherence) with patient self-recall identified as the common method of assessment. The most common reasons identified for patient nonadherence include the cost of therapy (even when the drugs are heavily subsidized), medication side effects, nonavailability of ARV drugs, and the stigma of taking the drugs. This manuscript highlights the policy and practice implications from these studies and provides recommendations for future ART program management.
authors.affiliation: Institute of Community Health, University of Houston, Texas Medical Center, Houston Texas 77030, USA.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Monjok
authors.forename: Andrea
authors.initials: A
authors.lastname: Smesny
authors.forename: Ita B
authors.initials: IB
authors.lastname: Okokon
authors.forename: Osaro
authors.initials: O
authors.lastname: Mgbere
authors.forename: E James
authors.initials: EJ
authors.lastname: Essien
references.citation: PLoS Med. 2007 May;4(5):e129
references.pmid: 17535100
references.citation: Am J Public Health. 2002 Mar;92(3):341-2
references.pmid: 11867303
references.citation: PLoS Med. 2005 Dec;2(12):e338
references.pmid: 16187735
references.citation: Bull World Health Organ. 2001;79(12):1145-51
references.pmid: 11799447
references.citation: AIDS. 2002 May 3;16(7):1051-8
references.pmid: 11953472
references.citation: J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S149-55
references.pmid: 17133199
references.citation: Ann Intern Med. 1999 Jul 20;131(2):81-7
references.pmid: 10419445
references.citation: AIDS Patient Care STDS. 2002 Nov;16(11):527-35
references.pmid: 12513901
references.citation: AIDS. 2001 Jun 15;15(9):1181-3
references.pmid: 11416722
references.citation: Niger J Med. 2005 Jul-Sep;14(3):290-4
references.pmid: 16350700
references.citation: Health Policy Plan. 2009 May;24(3):189-96
references.pmid: 19276155
references.citation: JAMA. 2006 Aug 9;296(6):679-90
references.pmid: 16896111
references.citation: Clin Infect Dis. 2006 Jun 1;42(11):1619-27
references.pmid: 16652320
references.citation: Afr J Med Med Sci. 2008 Mar;37(1):29-36
references.pmid: 18756852
references.citation: PLoS Med. 2009 Jan 27;6(1):e11
references.pmid: 19175285
references.citation: Soc Sci Med. 2003 Jul;57(1):13-24
references.pmid: 12753813
references.citation: J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):65-9
references.pmid: 16123684
references.citation: Lancet. 2005 Jan 22-28;365(9456):278-80
references.pmid: 15664207
references.citation: Clin Infect Dis. 2001 Oct 15;33(8):1417-23
references.pmid: 11550118
references.citation: AIDS. 2005 Aug 12;19(12):1243-9
references.pmid: 16052078
references.citation: Afr J AIDS Res. 2006 Sep;5(2):141-4
references.pmid: 25875238
references.citation: Arch Intern Med. 2009 Jul 13;169(13):1224-32
references.pmid: 19597072
references.citation: Curr Opin HIV AIDS. 2010 Jan;5(1):70-7
references.pmid: 20046150
references.citation: Int J STD AIDS. 2007 Nov;18(11):760-3
references.pmid: 18005510
references.citation: J Acquir Immune Defic Syndr. 2006 Sep;43(1):78-84
references.pmid: 16878045
references.citation: Ann Intern Med. 2000 Jul 4;133(1):21-30
references.pmid: 10877736
references.citation: J Infect Dev Ctries. 2008 Oct 01;2(5):369-72
references.pmid: 19745505
references.citation: AIDS Behav. 2009 Feb;13(1):42-5
references.pmid: 18521736
references.citation: AIDS. 2006 Jan 9;20(2):223-31
references.pmid: 16511415
references.citation: PLoS Med. 2006 Nov;3(11):e438
references.pmid: 17121449